A Phase 2 Study of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes Inadequately Controlled With Diet and Exercise
Clinical trial NCT06411275 · COMPLETED
Trial details
- NCT number
- NCT06411275
- Sponsor
- Shenzhen HighTide Biopharmaceutical Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-31
- Primary completion
- 2023-01-17
- Enrollment
- 113
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.